We caught up with Arda Ozcubukcu, Co-Founder and Director at NeuroSight, a harm reduction organisation preventing avoidable deaths and reducing drug-related ...
READ MOREWe caught up with Isaac Johnson CEO at Verinnogen, where they are designing tools for measuring the properties of 3D surfaces for use in oncology...
READ MOREWe caught up we caught up with Jenny Bailey, Chief Executive Officer at Ferryx, working on the development of innovative bacterial treatments for gastrointes...
READ MOREWe caught up with Dr. Edoardo Gaude, Co-Founder and Chief Scientific Officer at Pockit Diagnostics which is developing a tool for faster and more accurate...
READ MOREWe caught up with Henri Sant-Cassia, founding Director at The Conscious Fund, a global investor in early-stage ventures within psychedelic medicine, helping ...
READ MOREWe caught up with Abi Hannah, Co-Founder & CEO at Fertility Circle, a new kind of fertility platform. The purpose of article series ‘Product |...
READ MOREWe caught up John Maher, Chief Scientific Officer at Leucid Bio, a UK Biotechnology company focused on progressing novel CAR T therapies to improve treatment...
READ MOREWe caught up Alex Latyshev, Co-Founder and CEO at HIVE, a global network of next generation mental health centres specialising in psychedelic assisted psycho...
READ MOREWe caught up with Cosmo Feilding Mellen, Chief Executive Officer at Beckley Psytech Limited, a neuropharmaceutical company developing a pipeline of psychedel...
READ MOREOur interview with Gareth Morinan, Chief Scientific Officer at Machine Medicine Technologies, which has developed an AI platform for the objective measuremen...
READ MOREWe caught up with Michael O’Rourke, Chief Executive Officer at Re-Vana Therapeutics, which is developing sustained release biologics and small molecule drugs...
READ MOREWe caught up with Victoria Norman, CEO & Founder at Signum Health, who provide Virtual health care services, powered by their own digital interface. The...
READ MORE